Endometrial/Endometrioid Stromal Tumors With Extensive Whorling and CTNNB1 Translocation

被引:2
|
作者
Boyraz, Baris [1 ,5 ]
Paula, Arnaud da Cruz [2 ]
Deveraux, Kelly A. [4 ]
Tran, Ivy [4 ]
da Silva, Edaise M. [3 ]
Young, Robert H. [1 ]
Snuderl, Matija [4 ]
Weigelt, Britta [3 ]
Oliva, Esther [1 ]
机构
[1] Harvard Med Sch, Massachusetts Gen Hosp, Dept Pathol, James Homer Wright Pathol Labs, Boston, MA USA
[2] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY USA
[3] Mem Sloan Kettering Canc Ctr, Dept Pathol & Lab Med, New York, NY USA
[4] NYU, Langone Med Ctr, Dept Pathol, New York, NY USA
[5] Massachusetts Gen Hosp, Dept Pathol, 55 Fruit St,Warren Bldg, Boston, MA 02114 USA
关键词
endometrial stromal tumor; CTNNB1; beta-catenin; MENINGOTHELIAL-LIKE WHORLS; NUCLEAR BETA-CATENIN; ENDOMETRIAL; SARCOMAS; FEATURES; DIFFERENTIATION; LIPOSARCOMA; EXPRESSION; NEOPLASMS; UTERUS;
D O I
10.1097/PAS.0000000000002094
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Endometrial/endometrioid stromal tumors are rare and morphologically heterogenous, and their diagnosis may be challenging. We identified 3 endometrial/endometrioid stromal tumors with identical and previously undescribed histologic features and herein report their morphologic, immunohistochemical, and molecular profiles. Patients were 53, 62, and 79 years. Tumors were well-circumscribed, tan-yellow solid masses measuring 10.0, 11.0, and 18.7 cm, and were intramyometrial (n=2) or in the broad ligament (n=1). All showed small, tight whorls of epithelioid to slightly spindled tumor cells with minimal cytoplasm and negligible mitoses, multifocally associated with hyalinization and myxoid change set in a loose fibroblastic background with small, delicate vessels. This morphology was seen throughout in 1 tumor and in similar to 20% and 70% of the 2 others with the remaining areas showing sex cord-like differentiation. Tumor cells expressed CD10 (3/3, 1 focal), calretinin (3/3 diffuse), WT1 (3/3 diffuse), estrogen receptor (1/1, diffuse). RNA-sequencing was successful in 1 tumor and revealed a GREB1-CTNNB1 in-frame fusion. All 3 tumors harbored a CTNNB1 translocation by fluorescence in situ hybridization correlating with nuclear beta-catenin expression. Whole-genome DNA methylation analysis classified all 3 tumors within the low-grade endometrial stromal sarcoma reference class with flat copy number profiles. One patient (79-y-old) died of unrelated causes 2 months after surgery and the other 2 were alive without disease after 13 and 75 months. We have described a rare subset of endometrial/endometrioid stromal tumors with extensive whorling and a CTNNB1 translocation, expanding the morphologic and molecular spectrum of these neoplasms.
引用
收藏
页码:1285 / 1290
页数:6
相关论文
共 50 条
  • [1] Endometrial/oid Stromal Tumors with Extensive Whorling and CTNNB1 Translocation: A Report of Three Cases
    Boyraz, Baris
    Paula, Arnaud Da Cruz
    Devereaux, Kelly
    Tran, Ivy
    da Silva, Edaise M.
    Young, Robert
    Snuderl, Matija
    Weigelt, Britta
    Oliva, Esther
    LABORATORY INVESTIGATION, 2023, 103 (03) : S864 - S865
  • [2] Endometrial stromal tumor with whorling and GREB1::CTNNB1 fusion-a case report on a rare entity
    Bartu, Michaela Kendall
    Flidrova, Miroslava
    Nemejcova, Kristyna
    Hojny, Jan
    Dvorak, Jiri
    Michalova, Kvetoslava
    Dundr, Pavel
    VIRCHOWS ARCHIV, 2024, : 633 - 638
  • [3] CTNNB1 Mutations in Advanced Stage and/or Recurrent Endometrial Endometrioid Adenocarcinoma
    Singh, Charanjeet
    Routbort, Mark
    Broaddus, Russell
    MODERN PATHOLOGY, 2015, 28 : 307A - 307A
  • [4] Clinicopathologic and Immunohistochemical Correlates of CTNNB1 Mutated Endometrial Endometrioid Carcinoma
    Costigan, Danielle C.
    Dong, Fei
    Nucci, Marisa R.
    Howitt, Brooke E.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2020, 39 (02) : 119 - 127
  • [5] CTNNB1 Mutations in Advanced Stage and/or Recurrent Endometrial Endometrioid Adenocarcinoma
    Singh, Charanjeet
    Routbort, Mark
    Broaddus, Russell
    LABORATORY INVESTIGATION, 2015, 95 : 307A - 307A
  • [6] Clinical Significance of CTNNB1 Mutation and Wnt Pathway Activation in Endometrioid Endometrial Carcinoma
    Liu, Yuexin
    Patel, Lalit
    Mills, Gordon B.
    Lu, Karen H.
    Sood, Anil K.
    Ding, Li
    Kucherlapati, Raju
    Mardis, Elaine R.
    Levine, Douglas A.
    Shmulevich, Ilya
    Broaddus, Russell R.
    Zhang, Wei
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (09):
  • [7] Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles
    McConechy, Melissa K.
    Ding, Jiarui
    Senz, Janine
    Yang, Winnie
    Melnyk, Nataliya
    Tone, Alicia A.
    Prentice, Leah M.
    Wiegand, Kimberly C.
    McAlpine, Jessica N.
    Shah, Sohrab P.
    Lee, Cheng-Han
    Goodfellow, Paul J.
    Gilks, C. Blake
    Huntsman, David G.
    MODERN PATHOLOGY, 2014, 27 (01) : 128 - 134
  • [8] The Role of CTNNB1 in Endometrial Cancer
    Ledinek, Ziva
    Sobocan, Monika
    Knez, Jure
    DISEASE MARKERS, 2022, 2022
  • [9] Clinical impact of genetic alterations of CTNNB1 in patients with grade 3 endometrial endometrioid carcinoma
    Kato, Mayumi Kobayashi
    Asami, Yuka
    Takayanagi, Daisuke
    Matsuda, Maiko
    Shimada, Yoko
    Hiranuma, Kengo
    Kuno, Ikumi
    Komatsu, Masaaki
    Hamamoto, Ryuji
    Matsumoto, Koji
    Ishikawa, Mitsuya
    Kohno, Takashi
    Kato, Tomoyasu
    Shiraishi, Kouya
    Yoshida, Hiroshi
    CANCER SCIENCE, 2022, 113 (05) : 1712 - 1721
  • [10] Clinicopathologic Evaluation of CTNNB1 Mutations in High-Intermediate Risk Endometrial Endometrioid Carcinoma
    Haag, Jennifer G.
    Wolsky, Rebecca J.
    Moroney, Marisa R.
    Sheren, Jamie
    Sheeder, Jeanelle
    Bitler, Benjamin G.
    Corr, Bradley R.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2023, 42 (01) : 43 - 53